Published date:Dec 20 2024

Journal Title: Advances in Applied Nano-Bio Technologies

Issue title: Advances in Applied Nano-Bio Technologies: Volume 5 Issue 4

Pages:39 - 46

DOI: 10.18502/aanbt.v5i4.17961

Mohadeseh Parhizkarist_m_parhizkari@azad.ac.irDepartment of Biomedical Engineering, South Tehran Branch, Islamic Azad University, Tehran

In the Last years, graphene oxide and graphene quantum dots (GQDs) have received developed consideration due to their attributes such as small size and lightweight, fluorescence detection, liquid solvability, biomedicine, photo sensors, drug delivery, gene delivery, and cancer therapy refers to new approaches. Graphene quantum dots are fluorescent Graphene nanostructures with sizes Low. The fluorescence in GQDs emanates through two original fluorescence emissions from bond fracture energy transmission of interlace π-domains and in this material from surface deficiency. The GQDs have found applications in multiple areas such as nanomedicine. The GQDs have less toxicity and other particular properties in comparison to materials, quantum dots which make them superior properties for medical applications. In this review, the synthesis and fluorescence properties of the GQDs are illuminated and the latest progress in GQDs, Breast cancer therapy, their potential to pass Control Breast cancer, and Drug delivery are discussed. In this work, all studies and research are presented in the literature related to Blood cancer fighting using graphene and graphenebased conjugates. Performed a comprehensive summary of the latest progress of the graphene Blood cancer fight and highlighted the future challenges and the innovative possible theranostic applications.

Keywords: Graphene Quantum Dots, Graphene Oxide, Blood Cancer, Biomedicine

[1] Merino, S., et al., Nanocomposite hydrogels: 3D polymer–nanoparticle synergies for on-demand drug delivery. ACS Nano, 2015. 9(5): p. 4686-4697.

[2] Qin, S.Y., et al., Drug self-delivery systems for cancer therapy. Biomaterials, 2017. 112: p. 234-247.

[3] Hare, J.I., et al., Challenges and strategies in anti-cancer nanomedicine development: an industry perspective. Advanced Drug Delivery Reviews, 2017. 108: p. 25-38.

[4] Kong, T., et al., Doxorubicin conjugated carbon dots as a drug delivery system for human breast cancer therapy. Cell Proliferation, 2018. 51(5): p. e12488.

[5] Zhang, W., Z. Zhang, and Y. Zhang, The application of carbon nanotubes in target drug delivery systems for cancer therapies. Nanoscale Research Letters, 2011. 6(1): p. 555.

[6] Zhou, T., X. Zhou, and D. Xing, Controlled release of doxorubicin from graphene oxide based chargereversal nanocarrier. Biomaterials, 2014. 35(13): p. 4185-4194.

[7] Ali Mohammad, A., et al., Electric Field Induced Alignment of Carbon Nanotubes: Methodology and Outcomes, in Carbon Nanotubes, R. Mohammed Muzibur and A. Abdullah Mohamed, Editors. 2017, IntechOpen: Rijeka. p. Ch. 5.

[8] Mousavi, S.M., et al. Recent Advancements in Polythiophene-Based Materials and their Biomedical, Geno Sensor and DNA Detection. International Journal of Molecular Sciences, 2021. 22, DOI: 10.3390/ijms22136850.

[9] Mousavi, S.M., et al., Shape-controlled synthesis of zinc nanostructures mediating macromolecules for biomedical applications. Biomaterials Research. 26(1): p. 4.

[10] Monfared, M., et al., Emerging frontiers in drug release control by core–shell nanofibers: a review. Drug Metabolism Reviews, 2019. 51(4): p. 589-611.

[11] Azadi, S., et al., Antifungal activity of Fe3O4@SiO2/Schiff-base/Cu(II) magnetic nanoparticles against pathogenic Candida species. Scientific Reports, 2024. 14(1): p. 5855.

[12] Ashoori, Y., et al., Development and In Vivo Characterization of Probiotic Lysate-Treated Chitosan Nanogel as a Novel Biocompatible Formulation for Wound Healing. BioMed Research International, 2020. 2020(1): p. 8868618.

[13] Abootalebi, S.N., et al., Antibacterial Effects of Green-Synthesized Silver Nanoparticles Using Ferula asafoetida against Acinetobacter baumannii Isolated from the Hospital Environment and Assessment of Their Cytotoxicity on the Human Cell Lines. Journal of Nanomaterials, 2021. 2021(1): p. 6676555.

[14] Reina, G., et al., Promises, facts and challenges for graphene in biomedical applications. Chemical Society Reviews, 2017. 46(15): p. 4400-4416.

[15] Modugno, G., et al., Carbon nanomaterials combined with metal nanoparticles for theranostic applications. British Journal of Pharmacology, 2015. 172(4): p. 975-991.

[16] Geim, A.K. and K.S. Novoselov, The rise of graphene, in Nanoscience and technology: a collection of reviews from nature journals. 2010, World Scientific. p. 11-19.

[17] Fadeel, B., et al., Safety assessment of graphene-based materials: focus on human health and the environment. ACS Nano, 2018. 12(11): p. 10582-10620.

[18] Santhosh, K.K., M.D. Modak, and P. Paik, Graphene oxide for biomedical applications. Journal of Nanomedicine Research 2017. 5(6): p. 1-6.

[19] Chau, N.D.Q., et al., Elucidation of siRNA complexation efficiency by graphene oxide and reduced graphene oxide. Carbon, 2017. 122: p. 643-652.

[20] Konios, D., et al., Dispersion behaviour of graphene oxide and reduced graphene oxide. Journal of Colloid and Interface Science, 2014. 430: p. 108-112.

[21] Abdollahifar, A., et al., Fabrication of graphene oxide-lead oxide epoxy based composite with enhanced chemical resistance, hydrophobicity and thermo-mechanical properties. Advances in Polymer Technology, 2018. 37(8): p. 3792-3803.

[22] Wang, Y., et al., Graphene and graphene oxide: biofunctionalization and applications in biotechnology. Trends in Biotechnology, 2011. 29(5): p. 205-212.

[23] Kurapati, R., et al., Dispersibility-dependent biodegradation of graphene oxide by myeloperoxidase. Small, 2015. 11(32): p. 3985-3994.

[24] Kotchey, G.P., et al., A natural vanishing act: the enzyme-catalyzed degradation of carbon nanomaterials. Accounts of Chemical Research, 2012. 45(10): p. 1770-1781.

[25] Andón, F.T., et al., Biodegradation of single-walled carbon nanotubes by eosinophil peroxidase. Small, 2013. 9(16): p. 2721-2729.

[26] Bhattacharya, K., et al., Lactoperoxidase-mediated degradation of single-walled carbon nanotubes in the presence of pulmonary surfactant. Carbon, 2015. 91: p. 506-517.

[27] Girish, C.M., et al., Confocal Raman imaging study showing macrophage mediated biodegradation of graphene in vivo. Advanced Healthcare Materials, 2013. 2(11): p. 1489-1500.

[28] Gonçalves, G., et al., Nano-graphene oxide: a potential multifunctional platform for cancer therapy. Advanced Healthcare Materials, 2013. 2(8): p. 1072-1090.

[29] Farokhzad, O.C. and R.S. Langer, Impact of nanotechnology on drug delivery. ACS Nano, 2009. 3(1): p. 16-20.

[30] Bertrand, N., et al., Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Advanced Drug Delivery Reviews, 2014. 66: p. 2-25.

[31] Liu, R., et al., Bottom-up fabrication of photoluminescent graphene quantum dots with uniform morphology. Journal of the American Chemical Society, 2011. 133(39): p. 15221-15223.

[32] Yan, Y., et al., Recent advances on graphene quantum dots: from chemistry and physics to applications. Advanced Materials, 2019. 31(21): p. 1808283.

[33] Tabish, T.A., et al., Biocompatibility and toxicity of graphene quantum dots for potential application in photodynamic therapy. Nanomedicine, 2018. 13(15): p. 1923-1937.

[34] Saquib, Q., et al., Cellular and molecular toxicology of nanoparticles. Vol. 1048. 2018: Springer.

[35] Cai, Y., et al., Optical nano-agents in the second near-infrared window for biomedical applications. Chemical Society Reviews, 2019. 48(1): p. 22-37.

[36] Iannazzo, D., et al., A smart nanovector for cancer targeted drug delivery based on graphene quantum dots. Nanomaterials, 2019. 9(2): p. 282.

[37] Zhang, X., et al., Shining luminescent graphene quantum dots: Synthesis, physicochemical properties, and biomedical applications. Trac Trends in Analytical Chemistry, 2019.

[38] Şenel, B., et al., Graphene quantum dots: Synthesis, characterization, cell viability, genotoxicity for biomedical applications. Saudi Pharmaceutical Journal, 2019. 27(6): p. 846-858.

[39] Lee, C., et al., Measurement of the elastic properties and intrinsic strength of monolayer graphene. Science, 2008. 321(5887): p. 385-388.

[40] Kuilla, T., et al., Recent advances in graphene based polymer composites. Progress in polymer science, 2010. 35(11): p. 1350-1375.

[41] Cui, Y., S.I. Kundalwal, and S. Kumar, Gas barrier performance of graphene/polymer nanocomposites. Carbon, 2016. 98: p. 313-333.

[42] Sun, L., et al., A study of the polymerization of styrene initiated by K–THF–GIC system. European Polymer Journal, 2006. 42(2): p. 259-264.

[43] Xiao, M., et al., Synthesis and properties of polystyrene/graphite nanocomposites. Polymer, 2002. 43(8): p. 2245-2248.

[44] Li, Y., et al., Poly (propylene) nanocomposites containing various carbon nanostructures. Macromolecular Chemistry and Physics, 2011. 212(22): p. 2429-2438.

[45] Li, Y., et al., Poly (propylene)/graphene nanoplatelet nanocomposites: melt rheological behavior and thermal, electrical, and electronic properties. Macromolecular Chemistry and Physics, 2011. 212(18): p. 1951-1959.

[46] Zhu, Y., et al., Graphene and graphene oxide: synthesis, properties, and applications. Advanced Materials, 2010. 22(35): p. 3906-3924.

[47] Niyogi, S., et al., Solution properties of graphite and graphene. Journal of the American Chemical Society, 2006. 128(24): p. 7720-7721.

[48] Pendolino, F. and N. Armata, Graphene oxide in environmental remediation process. 2017: Springer.

[49] Pei, S. and H.M. Cheng, The reduction of graphene oxide. Carbon, 2012. 50(9): p. 3210-3228.

[50] Yoo, B.M., et al., Graphene and graphene oxide and their uses in barrier polymers. Journal of Applied Polymer Science, 2014. 131(1).

[51] Cheng, C., et al., Functional graphene nanomaterials based architectures: biointeractions, fabrications, and emerging biological applications. Chemical Reviews, 2017. 117(3): p. 1826-1914.

[52] Feng, R., et al., Impact of graphene oxide on the structure and function of important multiple blood components by a dose-dependent pattern. Journal of Biomedical Materials Research Part A, 2015. 103(6): p. 2006-2014.

[53] Liu, Z., et al., Interactions between solubilized polymer molecules and blood components. Journal of Controlled Release, 2012. 160(1): p. 14-24.